Stryker Total Current Liabilities decreased by 19.0% to $6.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.4%, from $7.93B to $6.32B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows an upward trend with a 9.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to current assets may signal liquidity pressure, while a decrease suggests improved short-term solvency.
This is the aggregate sum of all financial obligations that the company is required to settle within one year. It includ...
Standard across all industries; peers in the medical device sector typically manage these based on inventory turnover and payment terms.
total_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.25B | $4.45B | $4.55B | $4.41B | $4.40B | $4.57B | $6.30B | $5.87B | $6.58B | $7.46B | $7.92B | $6.96B | $6.93B | $7.67B | $7.62B | $7.93B | $7.29B | $7.41B | $7.79B | $6.32B |
| QoQ Change | — | +4.6% | +2.2% | -3.1% | -0.1% | +3.8% | +37.9% | -6.9% | +12.2% | +13.3% | +6.2% | -12.2% | -0.4% | +10.7% | -0.7% | +4.1% | -8.1% | +1.7% | +5.1% | -19.0% |
| YoY Change | — | — | — | — | +3.6% | +2.7% | +38.6% | +33.1% | +49.5% | +63.2% | +25.7% | +18.6% | +5.2% | +2.8% | -3.9% | +14.0% | +5.2% | -3.3% | +2.3% | -20.4% |